Do Doctors Recommend Routine Cancer Marker Tests?
Cancer screening is an important part of preventive healthcare, but not every test is suitable for everyone. Some people consider tumour marker blood tests as a way to detect cancer early, especially when they have no symptoms. However, these tests are not routinely recommended for screening the general population for most types of cancer.
A tumor marker test measures substances in the blood, urine, or body tissues that may be associated with cancer. Although these markers can provide valuable information in specific situations, they cannot reliably confirm or exclude cancer on their own.
Understanding when doctors recommend these cancer marker tests, what their results mean, and which screening methods are more appropriate can help you make informed decisions about your health.
What Are Cancer Marker Tests?
Tumour markers are substances produced by cancer cells or by normal cells in response to cancer. Doctors may measure them to help assess certain cancers, evaluate treatment response, or monitor for recurrence after treatment.
Examples include prostate-specific antigen (PSA), which may be used when assessing prostate cancer risk, and cancer antigen 125 (CA-125), which can be elevated in some people with ovarian cancer. Carcinoembryonic antigen (CEA) may help monitor certain colorectal cancers during and after treatment.
However, these substances are not exclusive to cancer. Benign conditions, inflammation, infections, and other medical factors can also cause elevated levels. Some cancers, meanwhile, do not produce detectable increases in the markers being measured.
Do Doctors Recommend Routine Testing for Everyone?
Generally, doctors do not recommend routine tumour marker testing as a universal cancer screening method for people without symptoms or specific risk factors.
Although a cancer marker test may seem like a convenient way to check for cancer through a blood sample, its accuracy depends on the marker, the disease being investigated, and the person’s clinical circumstances.
Testing people at low risk can produce false-positive results, meaning the test suggests a possible problem when cancer is not present. This may lead to anxiety, repeat blood tests, imaging examinations, or invasive procedures that carry their own risks.
False-negative results are also possible. A normal marker level does not guarantee that cancer is absent, and relying on it may create false reassurance or delay appropriate medical assessment. For these reasons, doctors usually select screening methods according to established guidelines, age, medical history, and individual risk factors.
When Might Doctors Recommend Tumour Marker Tests?
Tumour marker testing can be useful when it addresses a specific clinical question. Rather than ordering a broad panel without a clear reason, doctors consider the patient’s circumstances and the limitations of each marker.
- Monitoring an existing cancer: Certain markers can help doctors assess whether treatment is working or whether a cancer may have returned. Results are generally interpreted alongside symptoms, examinations, and imaging findings.
- Supporting diagnosis: When a patient has symptoms or abnormal findings, selected markers may provide additional information. However, they rarely establish a diagnosis independently, and further investigations may be required.
- Assessing specific risks: In selected situations, a doctor may discuss testing based on a person’s medical history, family history, or other risk factors. The benefits and limitations should be explained before testing.
The appropriate approach depends on the particular cancer and the reason for investigating it.
Which Cancer Screening Tests Are More Effective?
For people without symptoms, doctors generally recommend screening methods supported by evidence that they can detect specific cancers early and improve health outcomes. Depending on age, sex, medical history, and individual risk, recommended screening may include:
- Breast cancer: Mammography for eligible individuals.
- Cervical cancer: Human papillomavirus (HPV) testing or cervical cytology.
- Colorectal cancer: Stool-based tests or colonoscopy, depending on the screening programme.
- Lung cancer: Low-dose computed tomography for eligible people at high risk, particularly those with significant smoking histories.
These tests are designed for particular cancers and populations. A broad cancer marker panel cannot replace established screening recommendations. Your doctor can help determine which examinations are appropriate based on your circumstances.
Should You Request Cancer Marker Testing During a Health Screening?
If you are considering a cancer marker test as part of an annual health screening package, discuss its purpose with your doctor before proceeding.
Ask which cancer the test is intended to assess, whether it is recommended for someone with your risk profile, and what would happen if the result were abnormal. Understanding the possible benefits, limitations, and follow-up procedures can help you avoid unnecessary investigations.
If you have persistent symptoms, unexplained weight loss, unusual bleeding, or a new lump, seek medical assessment rather than relying on marker testing alone. Your doctor can recommend appropriate investigations based on your symptoms.
People with a strong family history of certain cancers or known inherited cancer-risk conditions may also benefit from a personalised screening plan.
Conclusion
Doctors generally do not recommend routine tumour marker testing for everyone because these tests have limitations when used to screen people without symptoms. However, they can be valuable for monitoring certain cancers, supporting diagnosis, and guiding treatment in selected circumstances.
The most appropriate approach is to choose evidence-based screening according to your age, medical history, and individual risk factors. Discuss your concerns with a healthcare professional to determine which tests are worthwhile and avoid investigations that may offer little benefit.
